agilon health inc
NYSE:AGL
agilon health inc
Cash Equivalents
agilon health inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
agilon health inc
NYSE:AGL
|
Cash Equivalents
$107.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash Equivalents
$380.1m
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-9%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash Equivalents
$686m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
CVS Health Corp
NYSE:CVS
|
Cash Equivalents
$8.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
Cigna Corp
NYSE:CI
|
Cash Equivalents
$7.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash Equivalents
$536.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
See Also
What is agilon health inc's Cash Equivalents?
Cash Equivalents
107.6m
USD
Based on the financial report for Dec 31, 2023, agilon health inc's Cash Equivalents amounts to 107.6m USD.
What is agilon health inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
0%
Over the last year, the Cash Equivalents growth was -78%.